LXRα improves myocardial glucose tolerance and reduces cardiac hypertrophy in a mouse model of obesity-induced type 2 diabetes

Cardiac LXR  protects against pathological cardiac hypertrophy and dysfunction by enhancing glucose uptake and utilization

(2015) M. V. Cannon et al.   EMBO Molecular Medicine

The liver X receptor agonist AZ876 protects against pathological cardiac hypertrophy and fibrosis without lipogenic side effects

(2015) Megan V. Cannon et al.   EUROPEAN JOURNAL OF HEART FAILURE

Liver X receptor agonist treatment attenuates cardiac dysfunction in type 2 diabetic db/db mice

(2014) Qing He et al.   Cardiovascular Diabetology

Insulin-Sensitizing Effect of LXR Agonist T0901317 in High-Fat Fed Rats is Associated with Restored Muscle GLUT4 Expression and Insulin-Stimulated AS160 Phosphorylation

(2014) Marcin Baranowski et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Activation of Liver-X-Receptor α But Not Liver-X-Receptor β Protects Against Myocardial Ischemia/Reperfusion Injury

(2014) Qing He et al.   Circulation-Heart Failure

Treatment with brain natriuretic peptide prevents the development of cardiac dysfunction in obese diabetic db/db mice

(2014) Eric Plante et al.   DIABETOLOGIA

Natriuretic peptides in cardiometabolic regulation and disease

(2014) Nora E. Zois et al.   Nature Reviews Cardiology

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

(2014) John J.V. McMurray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Liver X receptors preserve renal glomerular integrity under normoglycaemia and in diabetes in mice

(2013) Monika Patel et al.   DIABETOLOGIA

High-Fat Feeding-Induced Hyperinsulinemia Increases Cardiac Glucose Uptake and Mitochondrial Function Despite Peripheral Insulin Resistance

(2013) Anisha A. Gupte et al.   ENDOCRINOLOGY

Activation of Liver X receptors in the heart leads to accumulation of intracellular lipids and attenuation of ischemia–reperfusion injury

(2012) Peng Lei et al.   BASIC RESEARCH IN CARDIOLOGY

Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial Fibrogenesis

(2012) Lili Yu et al.   Circulation-Heart Failure

B-type natriuretic peptide and glycaemia: an emerging cardiometabolic pathway?

(2012) P. Welsh et al.   DIABETOLOGIA

Increased CD36 expression in middle-aged mice contributes to obesity-related cardiac hypertrophy in the absence of cardiac dysfunction

(2011) Miranda M. Y. Sung et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Acute Inhibition of Fatty Acid Import Inhibits GLUT4 Transcription in Adipose Tissue, but Not Skeletal or Cardiac Muscle Tissue, Partly Through Liver X Receptor (LXR) Signaling

(2010) B. A. Griesel et al.   DIABETES

Activation of liver X receptors with T0901317 attenuates cardiac hypertrophyin vivo

(2010) Irma Kuipers et al.   EUROPEAN JOURNAL OF HEART FAILURE

Liver X receptors are negative regulators of cardiac hypertrophy via suppressing NF- B signalling

(2009) S. Wu et al.   CARDIOVASCULAR RESEARCH

Downregulation of oxytocin and natriuretic peptides in diabetes: possible implications in cardiomyopathy

(2009) Jolanta Gutkowska et al.   JOURNAL OF PHYSIOLOGY-LONDON

Obesity Promotes Left Ventricular Concentric Rather Than Eccentric Geometric Remodeling and Hypertrophy Independent of Blood Pressure

(2008) A. J. Woodiwiss et al.   AMERICAN JOURNAL OF HYPERTENSION